Clinical Study of 177Lu-CTR-FAPI In the Treatment of Patients With Advanced, Metastatic Solid Tumors

This study is testing a new type of targeted radiation therapy called 177Lu-CTR-FAPI for people with advanced solid tumors that have spread and cannot be cured with standard treatments. This therapy uses a radioactive substance that seeks out cancer cells. **You may be eligible if...** - You have an advanced or metastatic solid tumor confirmed by biopsy - Standard treatments have failed, are not available, or you have declined them - Preferred tumor types include pancreatic cancer, triple-negative breast cancer, or soft tissue sarcoma - You have received at least 2 prior treatment lines for your cancer type - Your major organs are functioning adequately **You may NOT be eligible if...** - Your tumor has not been confirmed by biopsy or lab test - You have active, uncontrolled brain metastases - You have severe kidney or bone marrow problems - You are pregnant or breastfeeding - You have had recent major surgery or radiation therapy Talk to your doctor to see if this trial is right for you.